Health
Scientists are finally ready to roll out malaria vaccines after 30 years in development Bloomberg reports.
According to the World Health Organization, the malaria vaccinations will be carried out in Africa starting this month.
The vaccine during its trials prevented four in 10 malaria cases among children who received four doses in a large study.
GlaxoSmithKline Plc invested $1 billion in the development of the vaccine, meant to tackle the mosquito-borne disease that kills at least half a million people annually. It comes at a time when malaria is making a come back after declining for many years.
The malaria parasite’s uncanny ability to resist drugs and insecticides due to its complicated genes is making efforts to eliminate the disease more difficult.
Additionally, research into the vaccine is struggling to secure more international funding.
02:01
Kenya: Health workers increasingly concerned in wake of USAID cuts
01:21
Medical teams in DRC face difficult conditions as the race to contain Ebola outbreak
01:49
WHO sees encouraging signs in Congo Ebola fight but warns of surging cases
00:52
South African President Ramaphosa taken ill after BRICS summit
01:08
DRC Ebola outbreak passes 7,000 cases but officials say spread may have peaked
01:55
Ebola survivors in Beni take their lessons to schools as classes resume